Martin Bidlingmaier

Author PubWeight™ 91.12‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 2003 6.05
2 Automated chemiluminescence-immunoassay for aldosterone during dynamic testing: comparison to radioimmunoassays with and without extraction steps. Clin Chem 2006 2.20
3 Ghrelin suppresses glucose-stimulated insulin secretion and deteriorates glucose tolerance in healthy humans. Diabetes 2010 2.01
4 Central administration of ghrelin and agouti-related protein (83-132) increases food intake and decreases spontaneous locomotor activity in rats. Endocrinology 2004 1.70
5 Impaired glucose tolerance in rats fed low-carbohydrate, high-fat diets. Am J Physiol Endocrinol Metab 2013 1.54
6 The diagnosis and treatment of primary hyperaldosteronism in Germany: results on 555 patients from the German Conn Registry. Dtsch Arztebl Int 2009 1.46
7 Genetic determinants of serum testosterone concentrations in men. PLoS Genet 2011 1.45
8 A genome-wide association meta-analysis of circulating sex hormone-binding globulin reveals multiple Loci implicated in sex steroid hormone regulation. PLoS Genet 2012 1.23
9 High prevalence of reduced fecundity in men with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2009 1.17
10 Adrenal venous sampling: evaluation of the German Conn's registry. Hypertension 2011 1.15
11 A genome-wide association study identifies novel loci associated with circulating IGF-I and IGFBP-3. Hum Mol Genet 2011 1.10
12 Risk factors associated with a low glomerular filtration rate in primary aldosteronism. J Clin Endocrinol Metab 2008 1.08
13 Physiologic concentrations of exogenously infused ghrelin reduces insulin secretion without affecting insulin sensitivity in healthy humans. J Clin Endocrinol Metab 2013 1.08
14 Efficacy of 12-month treatment with the GH receptor antagonist pegvisomant in patients with acromegaly resistant to long-term, high-dose somatostatin analog treatment: effect on IGF-I levels, tumor mass, hypertension and glucose tolerance. Eur J Endocrinol 2006 1.05
15 Roux-en-Y gastric bypass surgery but not vertical sleeve gastrectomy decreases bone mass in male rats. Endocrinology 2013 1.05
16 Observational study mortality in treated primary aldosteronism: the German Conn's registry. Hypertension 2012 1.04
17 Induction of ketosis in rats fed low-carbohydrate, high-fat diets depends on the relative abundance of dietary fat and protein. Am J Physiol Endocrinol Metab 2010 1.04
18 The GOAT-ghrelin system is not essential for hypoglycemia prevention during prolonged calorie restriction. PLoS One 2012 1.01
19 Treatment of acromegaly with pegvisomant during pregnancy: maternal and fetal effects. J Clin Endocrinol Metab 2007 1.00
20 Prolonged zona glomerulosa insufficiency causing hyperkalemia in primary aldosteronism after adrenalectomy. J Clin Endocrinol Metab 2012 0.99
21 Time to recovery of adrenal function after curative surgery for Cushing's syndrome depends on etiology. J Clin Endocrinol Metab 2014 0.97
22 Short-term exposure to low-carbohydrate, high-fat diets induces low bone mineral density and reduces bone formation in rats. J Bone Miner Res 2010 0.96
23 Safety and efficacy of oral octreotide in acromegaly: results of a multicenter phase III trial. J Clin Endocrinol Metab 2015 0.93
24 Harmonization of growth hormone measurements with different immunoassays by data adjustment. Clin Chem Lab Med 2011 0.92
25 Fasting levels of ghrelin covary with the brain response to food pictures. Addict Biol 2012 0.92
26 (Still) longing for food: insulin reactivity modulates response to food pictures. Hum Brain Mapp 2012 0.92
27 Age below 40 or a recently proposed clinical prediction score cannot bypass adrenal venous sampling in primary aldosteronism. J Clin Endocrinol Metab 2014 0.92
28 Three-year efficacy and safety of LB03002, a once-weekly sustained-release growth hormone (GH) preparation, in prepubertal children with GH deficiency (GHD). J Clin Endocrinol Metab 2011 0.91
29 Pharmacokinetic and pharmacodynamic profile of a new sustained-release GH formulation, LB03002, in children with GH deficiency. Eur J Endocrinol 2008 0.90
30 Plasma- and urine concentrations of nitrite/nitrate and cyclic Guanosinemonophosphate in intrauterine growth restricted and preeclamptic pregnancies. Arch Gynecol Obstet 2006 0.90
31 Altered psychobiological responsiveness in women with irritable bowel syndrome. Psychosom Med 2012 0.90
32 The orphan receptor Gpr83 regulates systemic energy metabolism via ghrelin-dependent and ghrelin-independent mechanisms. Nat Commun 2013 0.90
33 Identification of a monoclonal antibody against the leptin receptor that acts as an antagonist and blocks human monocyte and T cell activation. J Immunol Methods 2006 0.90
34 Mental health in the aged: prevalence, covariates and related neuroendocrine, cardiovascular and inflammatory factors of successful aging. BMC Med Res Methodol 2010 0.88
35 Ghrelin drives GH secretion during fasting in man. Eur J Endocrinol 2002 0.88
36 An interaction between a neuropeptide Y gene polymorphism and early adversity modulates endocrine stress responses. Psychoneuroendocrinology 2011 0.88
37 Total adrenal volume but not testicular adrenal rest tumor volume is associated with hormonal control in patients with 21-hydroxylase deficiency. J Clin Endocrinol Metab 2010 0.87
38 Lack of dietary carbohydrates induces hepatic growth hormone (GH) resistance in rats. Endocrinology 2011 0.86
39 Age- and sex-specific reference intervals across life span for insulin-like growth factor binding protein 3 (IGFBP-3) and the IGF-I to IGFBP-3 ratio measured by new automated chemiluminescence assays. J Clin Endocrinol Metab 2014 0.86
40 CT mapping of the vertebral level of right adrenal vein. Diagn Interv Radiol 2015 0.86
41 Association of plasma aldosterone with the metabolic syndrome in two German populations. Eur J Endocrinol 2011 0.85
42 Ghrelin stimulation of growth hormone isoforms: parallel secretion of total and 20-kDa growth hormone and relation to insulin sensitivity in healthy humans. J Clin Endocrinol Metab 2012 0.85
43 Serum IGF-I is not a reliable pharmacodynamic marker of exogenous growth hormone activity in mice. Endocrinology 2011 0.84
44 Short stature caused by a biologically inactive mutant growth hormone (GH-C53S). J Clin Endocrinol Metab 2005 0.83
45 [Diagnosis of primary hyperaldosteronism]. Med Klin (Munich) 2007 0.83
46 A high aldosterone to renin ratio is associated with high serum parathyroid hormone concentrations in the general population. J Clin Endocrinol Metab 2013 0.83
47 Low-dose ghrelin infusion--evidence against a hormonal role in food intake. Regul Pept 2011 0.83
48 Low-carbohydrate high-fat diets: regulation of energy balance and body weight regain in rats. Obesity (Silver Spring) 2008 0.83
49 Commentary on the Endocrine Society Practice Guidelines: Consequences of adjustment of antihypertensive medication in screening of primary aldosteronism. Rev Endocr Metab Disord 2011 0.83
50 A pegylated growth hormone receptor antagonist, pegvisomant, does not enter the brain in humans. J Clin Endocrinol Metab 2010 0.82
51 The influence of mirtazapine on anterior pituitary hormone secretion in healthy male subjects. Psychopharmacology (Berl) 2002 0.82
52 Reboxetine acutely stimulates cortisol, ACTH, growth hormone and prolactin secretion in healthy male subjects. Psychoneuroendocrinology 2004 0.82
53 Predicting metabolisable energy in commercial rat diets: physiological fuel values may be misleading. Br J Nutr 2010 0.82
54 Pharmacokinetics and pharmacodynamics of GH: dependence on route and dosage of administration. Eur J Endocrinol 2007 0.82
55 Adrenal vein sampling using rapid cortisol assays in primary aldosteronism is useful in centers with low success rates. Eur J Endocrinol 2011 0.82
56 Low-carbohydrate high-fat diets in combination with daily exercise in rats: effects on body weight regulation, body composition and exercise capacity. Physiol Behav 2012 0.82
57 Growth hormone and insulin-like growth factor I insensitivity of fibroblasts isolated from a patient with an I{kappa}B{alpha} mutation. J Clin Endocrinol Metab 2010 0.82
58 Aldosterone and cortisol affect the risk of sudden cardiac death in haemodialysis patients. Eur Heart J 2012 0.81
59 Evaluation of a salivary based combined dexamethasone/CRH test in patients with major depression. Psychoneuroendocrinology 2002 0.81
60 Aldosterone excess impairs first phase insulin secretion in primary aldosteronism. J Clin Endocrinol Metab 2013 0.81
61 Clinical validation for the aldosterone-to-renin ratio and aldosterone suppression testing using simultaneous fully automated chemiluminescence immunoassays. J Hypertens 2015 0.81
62 Carbohydrate content of post-operative diet influences the effect of vertical sleeve gastrectomy on body weight reduction in obese rats. Obes Surg 2012 0.80
63 Short term regulation of aldosterone secretion after stimulation and suppression experiments in mice. J Mol Endocrinol 2009 0.80
64 Failure of temozolomide and conventional doses of pegvisomant to attain biochemical control in a severe case of acromegaly. Pituitary 2012 0.80
65 Blunted diurnal cortisol pattern is associated with frailty: a cross-sectional study of 745 participants aged 65 to 90 years. J Clin Endocrinol Metab 2014 0.80
66 A microsphere-based duplex competitive immunoassay for the simultaneous measurements of aldosterone and testosterone in small sample volumes: validation in human and mouse plasma. Steroids 2010 0.80
67 Isoenergetic feeding of low carbohydrate-high fat diets does not increase brown adipose tissue thermogenic capacity in rats. PLoS One 2012 0.80
68 Quantification of the soluble leptin receptor in human blood by ligand-mediated immunofunctional assay. J Clin Endocrinol Metab 2002 0.80
69 Ectopic growth hormone-releasing hormone secretion by a metastatic bronchial carcinoid tumor: a case with a non hypophysial intracranial tumor that shrank during long acting octreotide treatment. Pituitary 2007 0.79
70 Quantification of growth hormone in serum by isotope dilution mass spectrometry. Anal Biochem 2010 0.79
71 Chronic growth hormone excess is associated with increased aldosterone: a study in patients with acromegaly and in growth hormone transgenic mice. Exp Biol Med (Maywood) 2009 0.79
72 Role of placental growth hormone in the alteration of maternal arterial resistance in pregnancy. J Reprod Med 2007 0.79
73 A guide for measurement of circulating metabolic hormones in rodents: Pitfalls during the pre-analytical phase. Mol Metab 2012 0.79
74 Automated 22-kD growth hormone-specific assay without interference from Pegvisomant. Clin Chem 2012 0.78
75 The diagnosis of partial growth hormone deficiency in adults with a putative insult to the hypothalamo-pituitary axis. J Clin Endocrinol Metab 2007 0.78
76 Increased acylated plasma ghrelin, but improved lipid profiles 24-h after consumption of carob pulp preparation rich in dietary fibre and polyphenols. Br J Nutr 2007 0.78
77 Phenotype selection reveals coevolution of muscle glycogen and protein and PTEN as a gate keeper for the accretion of muscle mass in adult female mice. PLoS One 2012 0.78
78 Nicotine administration in healthy non-smokers reduces appetite but does not alter plasma ghrelin. Hum Psychopharmacol 2014 0.78
79 Early infant growth is associated with the risk of islet autoimmunity in genetically susceptible children. Pediatr Diabetes 2014 0.78
80 Genome-wide meta-analyses of plasma renin activity and concentration reveal association with the kininogen 1 and prekallikrein genes. Circ Cardiovasc Genet 2014 0.78
81 Preanalytical stability of adrenocorticotropic hormone depends on time to centrifugation rather than temperature. Clin Chem 2007 0.77
82 Systemic response of the GH/IGF-I axis in timely versus delayed fracture healing. Growth Horm IGF Res 2007 0.77
83 Lack of influence of somatic mutations on steroid gradients during adrenal vein sampling in aldosterone-producing adenoma patients. Eur J Endocrinol 2013 0.77
84 How robust are laboratory measures of growth hormone status? Horm Res 2005 0.77
85 Quality of life in patients with primary aldosteronism: gender differences in untreated and long-term treated patients and associations with treatment and aldosterone. J Psychiatr Res 2012 0.77
86 Endocrinological effects of mirtazapine in healthy volunteers. Prog Neuropsychopharmacol Biol Psychiatry 2002 0.77
87 A new nonisotopic, highly sensitive assay for the measurement of human placental growth hormone: development and clinical implications. J Clin Endocrinol Metab 2003 0.77
88 The relationship between alexithymia and salivary cortisol levels in somatoform disorders. Nord J Psychiatry 2008 0.76
89 Isolated GH deficiency type II: knockdown of the harmful Delta3GH recovers wt-GH secretion in rat tumor pituitary cells. Endocrinology 2010 0.76
90 Influence of pre-analytical conditions on the measurement of components of the GH/IGF axis in rats. Growth Horm IGF Res 2013 0.76
91 Indications, limitations and pitfalls in the determination of human growth hormone, IGF-I and their binding proteins. Pediatr Endocrinol Rev 2007 0.76
92 Gender differences in anxiety and depressive symptoms in patients with primary hyperaldosteronism: a cross-sectional study. World J Biol Psychiatry 2012 0.76
93 Purification of recombinant growth hormone by clear native gels for conformational analyses: preservation of conformation and receptor binding. Amino Acids 2010 0.76
94 Steroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronism. JCI Insight 2017 0.75
95 A robust method for genome-wide association meta-analysis with the application to circulating insulin-like growth factor I concentrations. Genet Epidemiol 2013 0.75
96 Spontaneous remission of idiopathic aldosteronism after long-term treatment with spironolactone: results from the German Conn's Registry. Clin Endocrinol (Oxf) 2012 0.75
97 Diastrophic dysplasia sulfate transporter (SLC26A2) is expressed in the adrenal cortex and regulates aldosterone secretion. Hypertension 2014 0.75
98 Gender-, strain-, and inheritance-dependent variation in aldosterone secretion in mice. J Endocrinol 2012 0.75
99 Failure of urine dipsticks to detect ketosis in rats. Obes Facts 2011 0.75
100 Utilization of a mutagenesis screen to generate mouse models of hyperaldosteronism. Endocrinology 2010 0.75
101 Performance evaluation of a fully automated immunoassay for the detection of human growth hormone on the Elecsys immunoassay system. Clin Lab 2014 0.75
102 Decreasing resistance in the maternal uterine and peripheral arterial system is apparently unrelated to plasma and urinary levels of nitrite/nitrate and cyclic-guanosinmonophosohate during the course of normal pregnancies. J Perinat Med 2003 0.75
103 Specific monoclonal antibodies and ultrasensitive immunoassays for 20K and 22K human growth hormone. Growth Horm IGF Res 2010 0.75
104 Pegvisomant-primed glucagon stimulation test in assessing GH reserve and GH/IGF kinetics in adults suspected of GH deficiency. Pituitary 2016 0.75
105 Sample pre-treatment determines the clinical usefulness of acid-labile subunit immunoassays in the diagnosis of growth hormone deficiency and acromegaly. Eur J Endocrinol 2007 0.75
106 Gaps in the traceability chain of human growth hormone measurements. Clin Chem 2013 0.75